site stats

Guangzhou virotech pharmaceutical co. ltd

WebAug 23, 2024 · Oncolytic virotherapy is rapidly progressing through clinical evaluation. However, the therapeutic efficacy of oncolytic viruses in humans has been less than expected from preclinical studies. We describe an anticancer drug screen for compounds that enhance M1 oncolytic virus activity in hepatocellular carcinoma (HCC). WebGuangzhou Virotech Pharmaceutical Co., Ltd. Guangzhou International Business Incubator, No. 3 Lanyue Road Science City of Guangzhou High-tech Industrial Development Zone Guangzhou, Guangdong 510663 China The sponsor address listed is the last reported by the sponsor to OOPD. ...

National Center for Biotechnology Information

WebDec 1, 2024 · Guangzhou Virotech Pharmaceutical Co., Ltd. Investigators PRINCIPAL_INVESTIGATOR: Liang Peng, MD, Third Affiliated Hospital, Sun Yat-Sen University Study record dates http://www.virot.net/col.jsp?id=120 file monitor tracking https://dslamacompany.com

Guangzhou Virotech Pharmaceutical Co., Ltd.:Company Profile

WebJun 21, 2024 · Guangzhou Virotech Pharmaceutical Co., Ltd, #3 Lanyue Road, Science Park, Guangzhou, 510663, China. Oncogene , 21 Jun 2024, DOI: 10.1038/s41388-021-01869-4 PMID: 34155344 Abstract Triple-negative breast cancer (TNBC) is the most aggressive molecular subtype among breast tumors and remains a challenge even for … http://en.gpc.com.cn/ WebDec 1, 2024 · Guangzhou Virotech Pharmaceutical Co., Ltd. Provider of Information About this Clinical Study Sponsor-Investigator: Liang Peng, Principle Investigator – Third Affiliated Hospital, Sun Yat-Sen University Overall Official (s) Liang Peng, MD, Principal Investigator, Third Affiliated Hospital, Sun Yat-Sen University Overall Contact (s) grofin finance

ViroTech - Medical

Category:Necroptotic virotherapy of oncolytic alphavirus M1 cooperated …

Tags:Guangzhou virotech pharmaceutical co. ltd

Guangzhou virotech pharmaceutical co. ltd

Virotech

WebAug 18, 2024 · Filed: November 12, 2024 Date of Patent: February 1, 2024 Assignee: GUANGZHOU VIROTECH PHARMACEUTICAL CO., LTD. Inventors: Guangmei Yan, Xiao Xiao, Jun Hu, Kai Li, Jiankai Liang, Yuan Lin, Haipeng Zhang, Suizhen Lin USE OF ALPHAVIRUS IN PREPARATION OF ANTITUMOR DRUGS WebLegal Name Guangzhou Virotech Pharmaceutical Co., Ltd. Company Type For Profit. Contact Email [email protected]. Phone Number 86 020 -32030745. Guangzhou …

Guangzhou virotech pharmaceutical co. ltd

Did you know?

WebOct 5, 2024 · 3 Department of International Cooperation, Guangzhou Virotech Pharmaceutical Co., Ltd., Guangzhou, China 4 Department of Pharmacology, School of Medicine, Jinan University, Guangzhou, China 5 Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China WebPhone Number 86 020 -32030745 Guangzhou Virotech Pharmaceutical Technology is a biotechnology company focusing on the R&D and production of oncolytic viruses for therapy. Lists Featuring This Company Asia Biotechnology Companies 4,983 Number of Organizations • $86.8B Total Funding Amount • 7,404 Number of Investors Track Private …

WebOct 6, 2024 · Long non-coding RNAs (lncRNAs), which are a class of non–protein-coding RNAs longer than approximately 200 nucleotides in length, are emerging as key epigenetic regulators of gene expression recently. Intensive studies have characterized their crucial roles in cutaneous biology and diseases. WebGuangzhou Virotech Pharmaceutical Co., Ltd. Active Ingredients. Drugs in Phase 1 Trials (2) apatinib recombinant oncolytic virus m1 Indications Experimental Indications (Clinical …

WebHigh-throughput anticancer drug screen identifies sensitizers for OV M1 To identify molecular targets to improve the efficacy of M1 virus, we performed a combinatorial drug screen of 350 anticancer small mole- cules that inhibit pathways involved in growth, metabolism, and apo- ptosis. WebNov 12, 2024 - GUANGZHOU VIROTECH PHARMACEUTICAL CO., LTD. Disclosed is use of alphavirus in preparation of antitumor drugs. The alphavirus is M1 virus or Getah virus. In addition, the specific tumor types sensitive to abovementioned alphavirus treatment are further determined, so as to provide a safe and effective solution for antitumor drug ...

WebViroTech seeks to understand what makes a company unique. We clearly defines outcomes and deliverables for a role as it fits into the greater goals of the organization to put the …

WebNational Center for Biotechnology Information grof in groficaWeb1 Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China. 2 Department of Research and Development, Guangzhou Virotech Pharmaceutical Co., Ltd., Guangzhou, China. PMID: 32829653 DOI: 10.1089/hum.2024.114 Abstract grofin ghanaWebGuangzhou Pharmaceutical Holdings Limited (GPHL) is a wholly state-owned enterprise authorized by Guangzhou municipal government to operate state-owned assets. GPHL is dedicated to the manufacture and sales of Chinese patent medicine with import and export trade as a sideline. Its representative products include Wanglaoji herbal tea. gro-fine weed and feed reviewsWebDec 11, 2024 · Guangzhou Virotech Pharmaceutical Co., Ltd. Information provided by (Responsible Party): Liang Peng, Third Affiliated Hospital, Sun Yat-Sen University Study Details Tabular View No Results Posted Disclaimer How to Read a Study Record No Study Results Posted on ClinicalTrials.gov for this Study gro fine weed \\u0026 feedhttp://www.virot.net/ grofin managershttp://www.virotechdiagnostics.com/en.html file motion for divorce case mass govWebGuangzhou Virotech Pharmaceutical Co., Ltd. is a company that provides Oncolytic virus and more. Guangzhou Virotech Pharmaceutical Co., Ltd. is headquartered in China … grofine crabgrass preventer